Literature DB >> 21342904

The science behind preparing and responding to pandemic influenza: the lessons and limits of science.

Anne Schuchat1, Beth P Bell, Stephen C Redd.   

Abstract

A strong evidence base provides the foundation for planning and response strategies. Investments in pandemic preparedness included support for research that aided early detection, response, and control of the 2009 influenza A (H1N1) (pH1N1) pandemic. Scientific investigations conducted during the pandemic guided understanding of the virus, disease severity, and epidemiologic risk factors. Field investigations also produced information that strengthened guidance for the use of antivirals, identification of target populations for monovalent pH1N1 vaccine, and refinement of recommendations for social distancing measures. Communication of this evolving evidence base was important to sustaining credibility of public health. Areas where substantial controversy emerged, such as the optimal approach to respiratory protection of healthcare workers, often suffered from gaps in the evidence base. Many aspects of the 2009-2010 pandemic influenza experience provide ongoing opportunities for additional study, which will strengthen plans for future pandemic response as well as control of seasonal influenza.

Entities:  

Mesh:

Year:  2011        PMID: 21342904     DOI: 10.1093/cid/ciq007

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  Household transmission of 2009 pandemic influenza A (H1N1): a systematic review and meta-analysis.

Authors:  Lincoln L H Lau; Hiroshi Nishiura; Heath Kelly; Dennis K M Ip; Gabriel M Leung; Benjamin J Cowling
Journal:  Epidemiology       Date:  2012-07       Impact factor: 4.822

2.  Putting program evaluation to work: a framework for creating actionable knowledge for suicide prevention practice.

Authors:  Natalie Wilkins; Sally Thigpen; Jennifer Lockman; Juliette Mackin; Mary Madden; Tamara Perkins; James Schut; Christina Van Regenmorter; Lygia Williams; John Donovan
Journal:  Transl Behav Med       Date:  2013-06       Impact factor: 3.046

3.  Protecting adults from influenza: tis the season to learn from the pandemic.

Authors:  Anne Schuchat; Jacqueline M Katz
Journal:  J Infect Dis       Date:  2012-07-10       Impact factor: 5.226

4.  Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.

Authors:  Rebekah H Borse; Sundar S Shrestha; Anthony E Fiore; Charisma Y Atkins; James A Singleton; Carolyn Furlow; Martin I Meltzer
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

Review 5.  Are we prepared to help low-resource communities cope with a severe influenza pandemic?

Authors:  Eric S Starbuck; Rudolph von Bernuth; Kathryn Bolles; Jeanne Koepsell
Journal:  Influenza Other Respir Viruses       Date:  2012-11-12       Impact factor: 4.380

6.  Incorporating research and evaluation into pandemic influenza vaccination preparedness and response.

Authors:  Tom T Shimabukuro; Stephen C Redd
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

Review 7.  Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness.

Authors:  Nina H Gobat; Micaela Gal; Nick A Francis; Kerenza Hood; Angela Watkins; Jill Turner; Ronald Moore; Steve A R Webb; Christopher C Butler; Alistair Nichol
Journal:  Trials       Date:  2015-12-29       Impact factor: 2.279

8.  Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza.

Authors:  Galina M Vodeiko; Jerry P Weir
Journal:  Influenza Other Respir Viruses       Date:  2011-09-08       Impact factor: 4.380

Review 9.  Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines.

Authors:  Jianfeng Zhang
Journal:  Viruses       Date:  2012-11-01       Impact factor: 5.048

10.  Development of a resource modelling tool to support decision makers in pandemic influenza preparedness: The AsiaFluCap Simulator.

Authors:  Mart Lambertus Stein; James W Rudge; Richard Coker; Charlie van der Weijden; Ralf Krumkamp; Piya Hanvoravongchai; Irwin Chavez; Weerasak Putthasri; Bounlay Phommasack; Wiku Adisasmito; Sok Touch; Le Minh Sat; Yu-Chen Hsu; Mirjam Kretzschmar; Aura Timen
Journal:  BMC Public Health       Date:  2012-10-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.